CLINICAL_TRIALS
trial_result
· 2018-01-12
Clinical Trial Update: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 trial update for LGD-6972 in type 2 diabetes mellitus has completed recruitment and status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ligand Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED